Showing 8971-8980 of 18563 results for "".
- Isotretinoin Slows Growth Rate in Teens, But Final Height Unchangedhttps://reachmd.com/news/isotretinoin-slows-growth-rate-in-teens-but-final-height-unchanged/2484962/Adolescents treated with isotretinoin for acne may experience temporary reductions in height velocity, but the medication does not appear to impact final adult height, according to a new retrospective cohort study published in the
- Unraveling the Impact of GDF3 Signaling in Age-Related Inflammationhttps://reachmd.com/news/unraveling-the-impact-of-gdf3-signaling-in-age-related-inflammation/2484949/University of Minnesota researchers show that macrophage-derived GDF3 sustains low-grade inflammation in older adults and increases vulnerability to infection, linking aged immune cell
- Rapid Adoption of SPRINT PNS Systems: Milestones and Clinical Impactshttps://reachmd.com/news/rapid-adoption-of-sprint-pns-systems-milestones-and-clinical-impacts/2484937/SPR Therapeutics announced that the SPR Therapeutics SPRINT PNS system has reached its 50,000th implant, re
- Revolutionizing Renal Replacement: Impact of the FDA's Breakthrough Device Designation for Holly Implantable Kidneyhttps://reachmd.com/news/revolutionizing-renal-replacement-impact-of-the-fdas-breakthrough-device-designation-for-holly-implantable-kidney/2484940/Nephrodite’s Holly implantable kidney
- Unlocking the Immune Code: Advances in Lichen Planus Pathogenesis and Emerging Therapieshttps://reachmd.com/news/unlocking-the-immune-code-advances-in-lichen-planus-pathogenesis-and-emerging-therapies/2484954/Once considered a relatively obscure dermatologic condition, lichen planus (LP) is gaining renewed scientific interest thanks to
- Most Insurers Cover Botulinum Toxin for Axillary Hyperhidrosis: Analysishttps://reachmd.com/news/most-insurers-cover-botulinum-toxin-for-axillary-hyperhidrosis-analysis/2484933/A new cross-sectional study published in the Journal of Drugs in Dermatology finds that while botulinum toxin is broadly covered by private insurers for the treatment of primary axillary hyperhidrosis, access barriers due to
- Evaluating Targeted Therapies for Inflammatory Skin Diseases: A Focus on Baricitinib in Lichen Planushttps://reachmd.com/news/evaluating-targeted-therapies-for-inflammatory-skin-diseases-a-focus-on-baricitinib-in-lichen-planus/2484952/Mayo Clinic investigators show that baricitinib produces rapid clinical benefit in liche
- Decoding Fetal Microcephaly: Genetic Insights from a Recent Prenatal Cohort Studyhttps://reachmd.com/news/fetal-microcephaly-genetic-prenatal-cohort/2484924/In a prenatal cohort, researchers found marked genotypic and phenotypic heterogeneity among fetuses with clinically identified microcephaly. In 197 fetuses referred fo
- Reframing MASLD: Oxygen-Nutrient Imbalance as a Key Driver of Diseasehttps://reachmd.com/news/masld-oxygen-nutrient-imbalance/2484916/In a new review, researchers reframe metabolic dysfunction-associated steatotic liver disease (MASLD) as a supply-demand injury in which excess portal caloric delivery can outpace hepatic oxyge
- Neonatal Outcomes in Preterm Infants by Gestational Age: Insights from a Retrospective Cohort Studyhttps://reachmd.com/news/neonatal-outcomes-preterm-infants-gestational-age/2484917/A recent cohort study provides new data on short-term neonatal outcomes across late‑preterm, early‑term, and full‑term births, quantifying risks that inform timing of elective delivery.